Therapeutic Asset Ratings
548 results matching 1 filter
133,990 assets · 8,802 sponsors · 3,128 indications
Methodology v0.2
Filters
1
Highest Rated
Advanced Phase
Alphabetical
Recently Updated
Asset
Sponsor
Phase
Rating
bd0801
Advanced Solid Tumor
Jiangsu Simcere Pharmaceutical Co., Ltd.
P2
CC
(46)
Endostar
Advanced Solid Tumor
Second Affiliated Hospital of Soochow University
P2
CC
(46)
Envofolimab
Advanced Solid Tumor
Jiangsu Simcere Pharmaceutical Co., Ltd.
P2
CC
(46)
Fam-Trastuzumab Deruxtecan-Nxki
Advanced Solid Tumor
Strata Oncology
P2
CC
(46)
Futibatinib
Advanced Solid Tumor
Taiho Oncology, Inc.
P2
CC
(46)
her3-dxd
Advanced Solid Tumor
Daiichi Sankyo
P2
CC
(46)
immunoglobulin G1-kappa, anti-[Homo sapiens CDH6(cadherin 6, K-cadherin (foetal kidney), cadherin 6 type 2)], humanized monoclonal antibody conjugated to deruxtecan, comprising a linker and a camptothecin derivative
Advanced Solid Tumor
Daiichi Sankyo
P2
CC
(46)
lm-168
Advanced Solid Tumor
LaNova Medicines Limited
P2
CC
(46)
Lorlatinib
Advanced Solid Tumor
Strata Oncology
P2
CC
(46)
ltc004
Advanced Solid Tumor
Cancer Institute and Hospital, Chinese Academy of Medical Sciences
P2
CC
(46)
Nilotinib
Advanced Solid Tumor
Convalife (Shanghai) Co., Ltd.
P2
CC
(46)
Thymalfasin
Advanced Solid Tumor
Second Affiliated Hospital of Soochow University
P2
CC
(46)
Rosuvastatin
Advanced Solid Tumor
PMV Pharmaceuticals, Inc
P1
CC
(46)
YH 001
Advanced Solid Tumor
Eucure (Beijing) Biopharma Co., Ltd
P1
CC
(46)
Amt-116
Advanced Solid Tumor
Multitude Therapeutics Inc.
P1/2
CC
(45)
Amt-253
Advanced Solid Tumor
Multitude Therapeutics Inc.
P1/2
CC
(45)
bat1308
Advanced Solid Tumor
Bio-Thera Solutions
P1/2
CC
(45)
Benmelstobart
Advanced Solid Tumor
Jinming Yu
P1/2
CC
(45)
br790
Advanced Solid Tumor
Shanghai Gopherwood Biotech Co., Ltd.
P1/2
CC
(45)
cvl006
Advanced Solid Tumor
Convalife (Shanghai) Co., Ltd.
P1/2
CC
(45)
db-1310
Advanced Solid Tumor
Synnovation Therapeutics, Inc.
P1/2
CC
(45)
Elironrasib
Advanced Solid Tumor
Revolution Medicines, Inc.
P1/2
CC
(45)
Immunoglobulin G1 [351-alanine,386-alanine,387-alanine] anti-(human epidermal growth factor receptor HER2) (human-Mus musculus monoclonal IMM2902 ?1-chain), disulfide with 1-125-signal regulatory protein ? [80-alanine] (human isoform 4 variant) fusion protein with peptide linker ((GGGGS)3) fusion protein with human-Mus musculus monoclonal IMM2902 ?-chain, dimer
Advanced Solid Tumor
ImmuneOnco Biopharmaceuticals (Shanghai) Inc.
P1/2
CC
(45)
Immunoglobulin G1-kappa, anti-[Homo sapiens ERBB2 (receptor tyrosine-protein kinase erbB-2, epidermal growth factor receptor 2, EGFR2, HER2, HER-2, p185c-erbB2, NEU, CD340)], humanized monoclonal antibody; conjugated to auristatin E
Advanced Solid Tumor
Shanghai Miracogen Inc.
P1/2
CC
(45)
Micvotabart
Advanced Solid Tumor
Pyxis Oncology, Inc
P1/2
CC
(45)
Showing 76 to 100 of 548 assets
Previous
Page 4 of 22
Next
